-
d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381
Available online at www.sciencedirect.com
ScienceDirect
jo ur nal home p ag e: www.int l .e lsev ierhea l th .com/
journa ls /dema
Review
Fiber glassbioactive glass composite for bonereplacing and bone
anchoring implants
Pekka Ka DepartmenUniversity ob City of Turc DepartmenUniversity
od Laboratory
a r t i c
Article histor
Received 8 S
Received in
30 Novembe
Accepted 7
Keywords:
Fiber glass
Bioglass
Bioactivce g
Fiber-reinfo
Implant
Cranial
CorresponE-mail a
http://dx.do0109-5641/. Vallittua,b,, Timo O. Nrhi c, Leena
Hupad
t of Biomaterials Science and Turku Clinical Biomaterials Centre
TCBC, Institute of Dentistry,f Turku, Turku, Finlandku Welfare
Division, Turku, Finlandt of Prosthetic Dentistry and Turku
Clinical Biomaterials Centre TCBC, Institute of Dentistry,f Turku,
Turku, Finland
of Inorganic Chemistry, Process Chemistry Centre, bo Akademi
University, Turku, Finland
l e i n f o
y:
eptember 2014
revised form
r 2014
January 2015
lass
rced composite
a b s t r a c t
Objective. Although metal implants have successfully been used
for decades, devices made
out of metals do not meet all clinical requirements, for
example, metal objects may interfere
with some new medical imaging systems, while their stiffness
also differs from natural bone
and may cause stress-shielding and over-loading of bone.
Methods. Peer-review articles and other scientic literature were
reviewed for providing up-
dated information how ber-reinforced composites and bioactive
glass can be utilized in
implantology.
Results. There has been a lot of development in the eld of
composite material research,
which has focused to a large extent on biodegradable composites.
However, it has become
evident that biostable composites may also have several clinical
benets. Fiber reinforced
composites containing bioactive glasses are relatively new types
of biomaterials in the eld
of implantology. Biostable glass bers are responsible for the
load-bearing capacity of the
implant, while the dissolution of the bioactive glass particles
supports bone bonding and
provides antimicrobial properties for the implant. These kinds
of combination materials
have been used clinically in cranioplasty implants and they have
been investigated also as
oral and orthopedic implants.
Signicance. The present knowledge suggests that by combining
glass ber-reinforced com-
posite with particles of bioactive glass can be used in cranial
implants and that the
combination of materials may have potential use also as other
types of bone replacing and
repairing implants.
2015 Academy of Dental Materials. Published by Elsevier Ltd. All
rights reserved.
ding author at: Institute of Dentistry, University of Turku,
Lemminkisenkatu 2, FI-20520 Turku, Finland. Tel.: +358 20 333
8332.ddress: Pekka.vallittu@utu. (P.K. Vallittu).
i.org/10.1016/j.dental.2015.01.003 2015 Academy of Dental
Materials. Published by Elsevier Ltd. All rights reserved.
-
372 d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381
Contents
1. Intro . . . . . 2. Struc . . . . . .
2.1. . . . . . 2.2. . . . . . .2.3. . . . . .
3. Bioac . . . . . 4. Impl . . . . . 5. Futu . . . . .
Ackn . . . . . Refer . . . . .
1. In
Biodegradaite materiadecades. Cin reconstrbeen used metals do
nisoelasticitcient (stresimplant [1when usedmay also inof
corrosioIn additiontics when allow postocontrast, dmade fromin a
polymcompositesearly 1960s1990s [911in
dentistryApplicationrestorativein orthodoapplicationimplant dein
cranial simplants blize certainthe possibinents to thhave
proverials in imimplants bing utilizata large numand implanrials
like titbeam comp
Regardleanchoring material of
emenroperole ass, ive gcrobviewe of
Str
ma. Th
at ers ir oriatrix
alsot ms, anf FRCth ausedfabrions.their
or cberhelsnd ore mduction . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . ture and material components of FRC . . . . . . . . . .
. . . . . . . . . . . . . . . Resin matrix . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . .Reinforcing bers . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . Biological
considerations . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . .
tive glasses . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . ant designs
preclinical studies . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . re direction of research . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
owledgements . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . ences . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
troduction
ble and biostable medical and dental compos-ls have been
developed considerably in recenturrently, they can be used in many
applicationsuctive medicine. Although metal implants
havesuccessfully for many years, devices made out ofot meet all
biomechanical requirements, such as
y of skeleton and bone and may lead to insuf-s-shielding) or
over-loading situations around the]. This problem has been
recognized specically
as metal implants in long bones. Metal implantsduce cytotoxic
reactions arising from the release
n products of metal ions, and nanoparticles [25]., metallic
objects interfere with medical diagnos-using magnetic resonance
imaging and do notperative radiation therapy to be performed [68].
Inurable and tough non-metallic composites can be
high-aspect ratio llers, namely bers embeddeder matrix. The rst
studies using ber-reinforced
(FRCs) in medicine and dentistry occurred in the, but more
extensive research started in the early]. Introduction of FRCs as
prosthodontic material
occurred in larger scale at the end of the 1990s.s of FRCs cover
several elds of dentistry from
dentistry to prosthodontics, but bers are also usedntics and
periodontology [12]. Besides the dentals, FRCs have started to be
used clinically as well inntistry, with the rst approved clinical
applicationsurgery [13]. Research to develop oral and
orthopedicased on FRC is ongoing. Implant applications uti-
biomechanical properties of FRC, and benet from
requirthe Euactive tive glBioactantimiThis reand us
2. FRC
FRC ismatrixgationthe bas bemer mmatrixCorrecprocestion
ostrengbeen tional conditlimits knowntional (KrencOral ament ality
of incorporating additional bioactive compo-e implant structure.
Particulates of bioactive glassd its suitability in this purpose
[14,15]. FRC mate-plantology have been focused initially on
cranialecause nonmetallic implants enable the increas-ion of
magnetic resonance imaging in identifyingber of infections related
to autologous bone apsts [16,17]. In implant dentistry, radiopaque
mate-anium and zirconia cause severe artifacts in coneuter
tomography images [18].ss of the location of the bone replacing or
boneimplant (maxillofacial, cranial or long bones), the
the implant and implant device have to fulll the
whereas coial implant
2.1. Res
ThermoplaExamples are polyethetal (PA), awhich are
glycidyl-A-methacryapolyesters h. . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 371
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 371. . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
371
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . 372. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. 373. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . 374. . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . 376. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . 377. . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . 378. . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . 378
ts of permanently implantable medical devices ofan Directive
classes 2B or 3. If the implant has anin tissues through its
components, such as bioac-the implant belongs to class 3 medical
devices.lass is considered an active component because ofial
nature, which is a desired property for implants.
describes the present status of the developmentnon-metallic
glass FRC bioactive glass implants.
ucture and material components of
de of reinforcing bers embedded in a polymere glass ber
properties tensile strength and elon-break partly control the
reinforcing capacity ofn polymers. However, several other factors
suchentation and length, ber adhesion to the poly-, and volume
fraction of bers in the polymer
contribute to the strength of the composite [19].aterial
selection, through composite fabricationd especially correct
design, enables the utiliza-
in applications where high static and dynamicre required. In
implant applications, bers have
as continuous unidirectional bers or bidirec-ic type
arrangements according to the loading
Anisotropicity of continuous unidirectional bers use in
applications where direction of load is notannot be predicted, but
then continuous unidirec-s provide the highest possible reinforcing
efciency
factor) against the known direction of stress [20].rthopedic
implants, which are under develop-anufactured using continuous
unidirectional bers
ntinuous bidirectional bers are utilized in calvar-s (Figs. 1
and 2).
in matrix
stic and thermoset resins are used in FRC implants.of
thermoplastics with biomedical applicationsylene (PE),
polyetheretherketone (PEEK), polyac-nd polyurethane (PU). Examples
of thermosetsutilized as biomaterials are epoxy polymer,
bis-dimethacylate (Bis-GMA), and triethyleneglycoldi-late (TEGDMA)
copolymer. Methacrylated dendriticave been tested also as resin
matrix for biomedical
-
d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381 373
Fig. 1 Schber-reinfoparticles of
FRCs with glinking dencompared trials used iTable 1.
Resin mtact to the dissolved fing the hydsilane coupof thermosto
bers careinforcing[23,24].
Polymerresins is bation of the or by increaversion degcan be
achimonomer cual monompolymer [27glass transithermal enunreacted
and react w
Scht wi
ndwng boematic drawing of the structure ofrced composite oral
implant, which contains
bioactive glass in the bone contacting surface.
Fig. 2 implanthe saallowiood success [21,22]. Thermosets exhibit
high cross-sity, which makes them stiffer and more fragileo
thermoplastics. Mechanical properties of mate-n implants and
properties of bone are presented in
atrix for the reinforcing bers is cured in con-reinforcing glass
bers (thermosets), or melted oror impregnation of bers
(thermoplastics). By siz-roxyl group covered surface of glass bers
withling agent and by using monomer resin systemet resin, the
chemical adhesion of polymer matrixn be obtained. In melted
thermoplastics, however,
bers are attached only physically to the surface
ization reaction of monomer systems of thermosetsed on free
radical (vinyl) polymerization. Initia-polymerization is made by
radiation of blue lightsing temperature, resulting to the monomer
con-ree of 6065% by light activation only, while 8590%eved in
post-polymerization by heat [25,26]. Higheronversion reduces the
quantity of leachable resid-ers and thus improves biocompatibility
of the]. Optimal post-curing temperature is close to thetion
temperature of the polymer, in which enoughergy is available to
create free volume, enablingcarboncarbon double bonds to form free
radicalsith each other [25].
2.2. Rei
Reinforcingsorbable glglass) andborosilicatebers. E-glmatrix
comronments. bioactive g(
-
374 d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381
Table 1 Mechanical properties of biomaterials andrelated ha
Material
PolymersPolyethylenPolyetherePolyacetal
PolyurethaPolymethyPolytetrauPolyethylenBis-GMA-TFiber-reinfoPEEK-carboGlass
ber/
UnidirecBidirectio
MetalsStainless sCobalt-chrTitanium a
Hard tissuCortical boCortical boCancellousEnamel Dentin
a Polymersb Flexural m
Table 2 bers [2913-93 [79
Compone
SiO2Al2O3CaO MgO B2O3K2O Na2O Fe2O3P2O5
effects of glass corrotion, the sttype of attture and tiber may
bmetal oxiddrawn frommost suitaare drawn glass formiber surfacwork
and may be elim
bers. In an acidic environment, incongruent dissolution fromthe
ber surface leads to differences in the surface and interior
sitio FRCNa2O
SiO. Becstems reaoduct. Thum
den strestem
record tissues [28,76,77].
Modulus(GPa)
Tensilestrength(MPa)
e (PE) 0.9 35therketone (PEEK)a 8.3 139(PA) 2.1 67ne (PU) 0.02
35lmethacarylate (PMMA)a 2.5 59oroethylene (PTFE) 0.5 28e
terepthalate (PET) 2.8 61EGDMA copolymera 8.0 52rced
compositesn/graphite berBis-GMA-TEGDMA
compodentalto 1% systemabilitythis syFor thiby
intrcontenaluminused intensilethe syof thetional (60 vol%) 20
1200b
nal (45/45) (60 vol%) 8 400b
teel 190 586omium alloy 210 1085lloy 116 965
esne (longitudinal) 17.7 133ne (transversal) 12.8 52
bone 0.4 7.484.3 1011.0 39.3
have been used as matrix polymer for FRC implants.odulus and
exural strength.
Nominal composition (wt%) of E and S glass] and bioactive
glasses 45S5, S53P4 [78], and].
nt Type of glass
E S 45S5 S53P4 13-93
5355 6265 45 53 531416 2025 2024 24.5 20 202024 1015 569
01.2
-
d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381 375
interfacial stresses and strains between the implant and
bonemore evenly than, for example, titanium implants. Further,using
FRCsof corrosionanoparticimplant anbearing arexation devrisk of
debr
Thermoof dimethathe potentmonomersIn contrasmonomer good
biocoperatures wrisk of residbeen demomonomersand less cy
Biologicdimethacryand animaity. E-glasswithout rein
broblaanother stuwere harveand on comCell
growthinvestigateactivity, osmaximal awere obsermarkers (othat the
faafter sevenwas observincreased mproductionration of osto
titaniumcell matura
3. Bio
Bioactive sgrafting mformation, of the inteexplained cglass
surfaThe biologiattachmenitor cells. Tsurface depthe
surfacesolution ra
Schematic drawing of the dissolution of bioactiven bone.
d knowledge of these reactions is a key to selectingve glasses
as components in FRC.
rst bioactive glasses consist of four oxides only: SiO2main
component (around 4550 weight%), around 20%
and Na2O, and a few percent of P2O5. The choice ofmpositions was
ingenious in several aspects. Firstly,active glasses consist of
elements that are present ately high concentrations in the body,
thus minimizingk of rejection by the tissue. Secondly, low silica
glassess the bioactive glasses have poor chemical durabilitytral to
slightly alkaline solutions (pH of blood plasma45). The reactions
at the bioactive glass surface startiately after implantation in
the tissue. When immersed
od plasma at 37 C, the glass primarily releases the bonded glass
network, modifying alkalis and alkaline
via rapid ion exchange with the H+ from the uid. Thehange leads
also to an increase in the pH of the interfa-lution. The higher pH
again leads to attack of the silicark leading to release of silica
as Si(OH)4 into the solutionrmation of silanols, SiOH at the glass
surface. In thetep, silanols condensate and repolymerize at the
glasse. All these steps lead to formation of a silica-rich
layerglass surface (Fig. 3). In the subsequent steps,
calciumosphate from the solution, and migrating from the bulkform
rst amorphous hydroxyapatite, Ca10 (PO4)6(OH)2en crystallize at
carbonate substituted hydroxyapatite(HA) at the glass surface (Fig.
3). This HA layer is instead of metal implants eliminates
formationn products and release of metal ions and metalles, which
may predispose aseptic loosening of thed unwanted tissue reactions.
When used in loadas, tribological properties of the composites
andices must be optimized to eliminate any potentialis formation
from the implant.set polymer FRC, made of epoxy polymers andcrylate
polymers, has been criticized regardingial toxic and sensitizing
(allergic) effects of its, which are present as residuals in the
FRC [34,35].t, thermoset polymers made of dimethacrylatesystems of
Bis-GMA and TEGDMA have shownmpatibility after polymerization at
elevated tem-ithout presence of oxygen, although potentialual
monomer effects have been discussed. It has
nstrated that hydroxylated metabolites of residual of Bis-GMA
were non-mutagenic, non-estrogenictotoxic than their parent
monomers [36].al testing of E-glass containing FRC withlate
thermoset polymer matric by cell culturesl testing have shown
acceptable biocompatibil-
bers having silane containing surface sizingsin matrix have
shown no signs of cytotoxityst or osteoblast cell culture studies
[3739]. Indy, rat bone-marrow derived osteoblast-like cellssted and
cultured on experimental FRC platesmercially pure titanium plates
as control [40].
and differentiation kinetics were subsequentlyd by evaluating
proliferation, alkaline phosphataseteocalcin, and bone sialoprotein
production. Thelkaline phospatase activities on FRC and titaniumved
after three weeks. Expression of osteoblasticsteocalsin and
sialoprotein production) indicatedstest osteogenic differentiation
took place on FRC
days. In contrast, a slower differentiation processed on
titanium than on FRC, as was conrmed byRNA expression of ostecalsin
and sialoprotein
. It was concluded that the proliferation and matu-teoblast-like
cells on FRC appear to be comparable. In addition, presence of
bioactive glass enhancedtion.
active glasses
ilicate glasses were originally designed as boneaterials, which
do not induce brous capsulebut bond directly to the living tissues.
Formationrfacial bonding between the glass and tissue isommonly as
a series of reactions starting at the
ce followed by a series of biological reactions [41].cal
reactions include adsorption of growth factors,t, proliferation,
and differentiation of osteoprogen-he different reaction steps
taking place at the glassend mainly on the glass composition but
also on
topography, surface area of glass to volume oftio, and ow of the
uid along the glass surfaces.
Fig. 3 glass i
Detailebioacti
Theas the of CaOthe cothe biorelativthe rissuch ain
neu7.357.immedin blolooselyearthsion exccial sonetwoand fonext
ssurfacat the and phglass, and thlayer
-
376 d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381
compatible with the biological apatite and provides an
inter-facial bonding between the material and tissue [41].
Today,materials, are commo
Formatiregarded asgel like stration
sitescompatiblehydroxyapalayer formaa biocompaHydroxyapof
bioactiveHydroxyapas well as oregions surers containdissolving
ftion on biocreported atpolymers a
Today, inknown to senhancing ion dissoluconcentrataffects the
[5054].
Several bioactive glpolymers. Msurroundinconductivedeal with
dscaffolds inscaffold thultimately solve and boral, and opolymers
aglass is thotion [56]. Defrom the gl
When utration of tgive the deentrapped extracellularapidly
enoions, whichfunctions tof bone. Abe varied wbe tailoredglasses
45Sin biopolymS53P4 are received thmedical de
Ins one-1,
/min
nd Sainl
to alsed bsitios haver coand a optof 45f freuffersamphss for
phitioneasesS53P
the to 45S5 suggests that the calcium concentration has notd
values needed for precipitation yet. Clearly lower val-r all ions
are shown for glass 13-93, while the E-glasssition is practically
inert by showing only some verynitial dissolution. Finally, the pH
values of the solutions
the dissolution trends; the highest initial dissolu-r 45S5 and
clearly lower values for S53P4 and 13-93.ssolution proles in Fig. 4
clearly show that the glassomposition controls the initial and the
overall dissolu-tes. Although glass 45S5 gives rapid initial
dissolution,ormation of hydroxyapatite at the particle surfaces
maythe ion release rate at longer times. Thus, S53P4 maynterest to
satisfy a critical concentration of a speciceasing from the glass.
The particle size of the glasses
the dissolution; the smaller the particles, the
highercentration. For example, using bioactive glasses as thin
uous bers in a polylactide composite gave rapid dis-n due to the
high surface area and modied surfacesition as compared to the bulk
glass [59].which are able to form HA layer at their surfacenly
termed as bioactive.on of the silica gel and the HA layer are
generally
essential characteristics of bioactive glasses. Theucture of the
silica layer provides exible nucle-
for apatite, with a size in the nanometre scale with the
biological apatite crystals [42]. However,tite precipitation
without extensive silica-richtion in vitro has been reported also
at the surface oftible glass in close vicinity to bioactive glass
[43].atite is known to also form in vitro on a composite
glass bers and a non-degradable polymer [44].atite formed on the
bers within the composite,n the surface of the polymer of the
composite inrounding the bers. Interestingly, these halo lay-ed
silicon, calcium, and phosphorus. Thus, the ionsrom the bioactive
glasses may induce layer forma-ompatible surfaces. Similar halo
effect in vitro was
surfaces of composites consisting of biodegradablend bioactive
glass spheres or particles [4547].organic ions dissolving from
bioactive glasses aretimulate the osteogenesis and angiogenesis,
thusregeneration of bone tissue [48,49]. In addition, thetion from
the bioactive glasses changing the ionion and increasing the pH of
the interfacial solutionviability of several anaerobic and aerobic
bacteria
studies report developing composites in whichass particles or
bers are used to reinforce organicoreover, the bioactive glass,
when exposed to the
g extracellular uids, gives the composite osteo- and
osteoinductive properties [55]. Most studiesevelopment of highly
porous temporary templates,
which the organic polymer is bioresorbable. Theus allows
three-dimensional growth of bone, andboth the bioactive glass and
the polymer will dis-e replaced by new tissue. In contrast, the
cranial,rthopedic FRC implants contain biostable organicnd glass
bers. In such structures, the bioactiveught to provide
osteoinduction and osteoconduc-pending on the implants design, the
ions releasedass may give antimicrobial effects.sed in the FRC
implants, composition and concen-he bioactive glass should be
optimized carefully tosired bioactivity. If used as particles, they
must bewithin the FRC layers while being exposed to ther uids.
Optimally, the bioactive glass dissolvesugh to release critical
concentrations of inorganic
activate and stimulate the bodys own cellularo anchor the
implant via ingrowth and ongrowths the oxide composition of
bioactive glasses canithin wide ranges, their ion dissolution rate
can
for controlled ion release. Melt-derived bioactive5, S53P4, and
13-93 have been studied frequentlyer composites. At present, these
glasses 45S5 and
the only melt-quenched compositions that havee US Food and Drug
Administration acceptance forvices to be used inside the human
body. Because
Fig. 4 glassepropan0.2 ml
45S5 aused minally been ucompoglassepolymP, Ca, plasmticles ow
odiol)-bof the the gratrationcalciumIn addSi incrGlass for allpared
reacheues focompoearly iconrmtion foThe dioxide ction raearly
faffect be of iion relaffectsthe concontinsolutiocompouence of
initial ion dissolution from bioactive the pH of TRIS
(2-amino-2-hydroxymethyl-3-diol)-buffered solution at 40 C. Fluid
ow rate, particle size 300500 m.
53P4 easily crystallize in glass fabrication, they arey as
particles. However, 13-93 was developed orig-low drawing of
continuous bers, and thus it hasoth as bers and particles in
composites. The oxidens of the glasses are given in Table 2. All
thesee been reported to induce bioactivity to organicmposites. Fig.
4 shows the initial dissolution of Si,Na, measured with ICP-OES
(inductively coupledical emission spectrometry) from 300500 m
par-S5, S53P4, and 13-93 in a continuous 0.2 ml/minsh TRIS
(2-amino-2-hydroxymethyl-propane-1,3-ed solution at 40 C [57,58].
The initial dissolutione ions from particles also of E-glass is
indicated in
(Fig. 5ad). Glass 45S5 shows the highest concen- all but
phosphate, suggesting that formation ofosphates starts rapidly at
the particles surfaces., the concentration of Na is very high,
while that of
rapidly to values that indicate a level of saturation.4 also
shows relatively high initial concentrationsions. The higher
phosphate concentration com-
-
d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381 377
a b
c
Fig. 5 Dis3-diol)-buff
When uof the partdense commay lead ting bioactilayer retardthe
polymethe additiorelease ratethe implanglass compthe access oglass
to ind
4. Im
Numerous explore bioof those excles have bor incorporstructural
dtive glass those madeimplants hdsolution of (a) Na, (b) Ca, (c) Si
and (d) P from bioactive glasses inered solution at 40 C. Fluid ow
rate 0.2 ml/min, particle size 30
sing bioactive glasses in composites, the adhesionicles or bers
also affects the dissolution rate. Inposites, formation of
capillaries at the interfaceso enhanced dissolution of the glass
[47]. Coat-ve glass particles or ber with a suitable sizings the
dissolution and increases the adhesion tor [60,61]. Thus, depending
on the FRC structure,nal coating may help in controlling the
initial ion
from the glasses and thus aid osseointegration oft. FRC implant
porosity, uid ow rate, bioactiveosition, concentration, and
particle size, as well asf the particles to uid, control the
capability of theuce osteoinduction and osteoconduction.
plant designs preclinical studies
animal experiments have been carried out tological responses to
E-glass FRC implants. In manyperimental FRC materials, bioactive
glass parti-een embedded in the surface of the FRC implant,ated
inside the implant construction. There areifferences in the
implants made of FRC and bioac-for the lamellar cranial bone
applications, and
for oral and orthopedic applications in which theave to
withstand higher mechanical loads. Cranial
implants hfor free painner laminof implantother autolfactors,
intinteract wiin the applto withstanof continuoglass are in(Fig.
2). Exptive isles onosteogenestion proces
FRC biical animafor orthopeneck applicial defect mfor use as
lstrength anwith local to test the made of unface was c TRIS
(2-amino-2-hydroxymethyl-propane-1,0500 m.
ave sandwich structure, where there is a spacerticles of
bioactive glass between the outer andates (Fig. 1). Mechanism of
function of this kind
is based on absorption of blood and cells withogous bone forming
components, such as growtho the interlaminate space where they are
able toth particles of bioactive glass. On the other hand,ications
where the implant is designed primarilyd a higher load, i.e. they
are made predominantlyus unidirectional bers, the particles of
bioactivecorporated in the surface of the FRC implant onlyosed
particles of bioactive glass form osteoconduc-
the implant surface, which are actively promotingis and guiding
new bone formation by surface reac-ses of BG particles.oactive
glass implants have been tested in preclin-l tests for head and
neck applications as well asdics and oral implantology
applications. Head andations have been tested with critical size
calvar-odel with rabbits [27,62]. FRC have the potential
oad-bearing dental and orthopedic implants if thed elastic
modulus of FRC implant can be matchedrequirements. An animal study
was carried outin vivo performance of novel orthopedic
implantsidirectional glass FRC bers [14]. The implant sur-overed
with particles of bioactive glass. Control
-
378 d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381
implants were made of surface-roughened titanium. After ahealing
period, the femurs were harvested and analyzed byradiographraphy)
imarecovery wnal analyfractures inanalysis deof the
titanconsequentime of theretrieved fethe groupsreturned timplants
sadverse tis
Most coof specic sosseointegrical modior acid etcincrease
imlogically acbeen showhave been results sugare adequatant role
inare known response. Hremain actand fabricathe outer ican be
embufacturing used in pabone bondbers, whetial to
chancoagulation
Osseoinconstant bobution of loby the prothe implanthe
highestimplant anmanufactuto distributcortical bonloads [67].
Itributed evhas good padvantage tive for tradresist mechimplant
alsThreads oftionally orisufcient s
conditions [6]. In clinical environments, particles of
bioac-tive glass on FRC implants conduct bone formation along
the
implce. I
bos [69ive mempt
prepl toointraetallhe hh meC, o
nsidet dagivaltatio
sing of frents
leve thaed suival
ic pro imperal,ed by
Fu
teriaradaue enl exper co
can bediciber t kna thn altg auts [aps tly uonta
bioay, exand liniccicate bmec
in lxten. Alsy, torsional testing, micro-CT (computer
tomog-ging, and hard tissue histology. The functionalas
unremarkable in both groups, although thesis revealed two healed
undisplaced peri-implant
the femurs with FRC implants. Finite elementmonstrated
differences in stress-shielding effectsium and FRC implants, but
the expected biologicalces did not become evident during the
follow-up
animal study [14,68]. Biomechanical testing of themurs showed no
signicant differences between. The torsional strength of the xed
bones hado the level of contralateral intact femurs. Bothhowed
ongrowth of intramedullary new bone. Nosue reactions were
observed.mmercially available oral implants have some kindurface
treatment, which enables better and fasteration. Surface treatments
involve only topograph-cations with the means of air-particle
abrasionhing or combination thereof. These treatmentsplant surface
area, but as such they are not bio-tive. In many studies, calcium
phosphates haven to improve osseointegration. Various
methodsdeveloped for implant coatings and currently thegest that
the quality and thickness of such coatingste. It is clear that
surface chemistry plays an impor-
the osseointegration process. Ions such as uorideto improve bone
formation and enhance osteoblastowever, it is not known how long
implant surfacesive after initial healing process [63]. FRC
structuretion process offer unique possibilities for
tailoringmplant surface zone. Biologically active materialsedded in
the composite structure during the man-process. Bioactive glasses,
for example, have beenrticulate form on the implant surface to
enhanceing. Interestingly it has been shown that E glassn exposed
on the implant surface, have the poten-ge surface charge and
enhance, for example, blood
process [64,65].tegration is a dynamic process, which includesne
remodeling toward mechanical loading. Distri-ading forces into bone
tissue is dictated primarilyperties of an implant material and the
design oft as such. In the case of titanium oral implants,
mechanical stress concentrates on the neck of thed on the top of
screw threads [66]. Many implantrers have introduced implant
designs which aime the load on the marginal bone in a manner thate
can be maintained even under extensive occlusaln the case of FRC
implants, mechanical load is dis-enly to the surrounding bone
structure [68], whichotential for maintaining bone. This is an
obviousexplaining why FRC offers an interesting alterna-itional
titanium implants. Unidirectional bers cananical loading, but the
strength of screw type oralo depends also on the strength of
implant threads.
FRC implants have been reinforced with bidirec-ented ber
fabrics, which have proven to providetrength against mechanical
loading in laboratory
entire interfaformedthreadexcess
Attcan benaturanium, and mover, tthroug[72]. FRout cowithou
Ginimplanincreain caseabutmTissuelogicalnot neof gingesthetof
FRCin genadjust
5.
Biomabiodegin tissclinicapolymwhichtive mglass Currenthe
ideoffer aof usinimplanbone presenglass ctainingsurgerto expterm
cfor speadequthe biormedused ementsant surface, which strengthens
the implant-bonen the case of fully osseointegrated implants,
newlyne structure lls the space between the implant71] and protects
the FRC implant threads fromechanical loads.s to make oral implants
or implant abutments thatared in the oral cavity on a similar
manner with
th have not been very successful. In the case of tita-oral
preparation of implant abutments is difcultic debris is released
into surrounding tissues. More-eat generated into the surrounding
bone structuretal can lead to bone necrosis and loss of an
implant
n the other hand, is relatively easy to prepare with-rable heat
generation to use for crown abutmentsmaging the surrounding bone or
gingival tissues.
attachment starts to form immediately uponn on oral implant
surface [73]. There has been anconcern about the stability of
gingival attachmentequent disconnection and reconnection of
implant
during the restoration phase of treatment [74,75].l implants
are, in this consideration, far more bio-n bone level implants.
Tissue level implants dobgingival implant manipulation. However, in
case
retraction or too big misalignment of will causeblems as implant
neck becomes visible. One piece
lant has the same benets as tissue level implants but in case of
visible implant margin, FRC can be
normal tooth preparation process.
ture direction of research
l researchers have put a lot of effort into developingble
polymer based materials, which could be usedgineering scaffolds and
implants. However, theirloitation is still very limited. Biostable,
bioactivemposites offer an interesting group of materials,e used in
a wide range of treatments in reconstruc-ne and dentistry. One
example of such materials isreinforced composites containing
bioactive glass.owledge obtained from clinical studies supportsat
bioactive ber reinforced cranial implants canernative route for
cranial reconstructions insteadtologous bone aps or bulk polymer
and metal
13,16]. Surgical site infections and resorption ofare causing
the most frequent complications in thesed cranioplasties. Although
glass FRC, bioactiveining implants (glass ber reinforced implants
con-ctive glass particles), have good potential in cranialtensive
in vitro and in vivo research is still neededthe areas of
indications. Evaluation of their long-al outcomes and tailoring of
the implant designs
applications is needed urgently. Besides the
knowniocompatibility and bone bonding properties withhanical
properties, all requirements have to be con-ong term clinical
trials before glass FRC can besively in oral implant and orthopedic
implant treat-o, question of potential estrogenic effect of
certain
-
d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381 379
resin systems deriving from bis-phenol A/bis-GMA needs to
beanswered [8mize implatraumatologlasses is wabout the aon a
molecrial interaccomposite
Acknowle
Authors exthe BioCitybiomateriaimplant restion (TEKES(Grant:
NEWsity Hospita
r e f e r e n
[1] HuiskeDiagno1993;64
[2] Bonelreinforimplan1981;2:
[3] Park JBPlenum
[4] SebecicAggresarthopdebris:
[5] Roesslecobaltismall darthophttp://d
[6] Sawyerscreenibiomed2001;12
[7] Shellocmagne1.5-tes
[8] Shellocof magMagn R
[9] Smith polyme
[10] Goldbeof matrintende1994;28
[11] VallittudenturOral Re
[12] VallittucompoDent 20
[13] Aitasalo KM, Piitulainen J, Rekola JM, Vallittu PK.
Craniofacialne rempoao Drandtimiplan09;31ltola
Novecons38.neybumamplijury artinhackllowimplitientusis
intenmpoplanead llittuatinlingapenchchniljaneethacd de05;16usa
Sne dmpoater Rsen yondchnoatinlie effoperher Cutzfeantitd in
00;28in SHodulurinkaring usa Sonomotopi Matssilaexuraater 2erem:
Ehreitorsasskkerrstr
E-glaysico0,81]. Therefore, more research is required to opti-nt
geometries for oral implantology as well as forgy and
orothopaedics. Surface kinetics of bioactiveell documented, but
there is still very limited datactual biological mechanisms of
tissue integrationular level. Deep understanding of tissue
biomate-tions would aid in developing strong and effectivematerials
for reconstructive medicine at large.
dgements
press their gratitude to the researcher team of Turku
Biomaterials Research Program (www.
ls.utu.) and principal nancing partners of the FRCearch: Finnish
Agency for Technology and Innova-), Academy of Finland and European
CommissionBONE NMP3-CT-006-026279-2) and Turku Univer-l.
c e s
ss R. Failed innovation in total hip replacement.sis and
proposal for a cure. Acta Orthop Scand:699716.d W, Grynpas M, Tully
AE, Bowman J. Hydroxyapatiteced polyethylene a mechanically
compatiblet material for bone replacement. Biomater18591., Lakes
RS. Biomaterials: an introduction. New York:
Press; 1992. B, Japjec M, Dojcinovic B, Zgaljardic I, Staresnic
M.sive granulomatosis after cementless total hiplasty as a result
of inammatory reaction to metal
case report. Acta Clin Croat 2013;52:4926.r PP, Witt F, Efe T,
Schmitt J. Arthroprostheticsm and pseudotumour also occur in
patients withiameter femoral ball head metal-on-metal total
hiplasties. BMJ Case Rep 2014;28,x.doi.org/10.1136/bcr-2013-203362,
pii:bcr2013203362.-Glover AM, Shellock FG. Pre-MRI procedureng:
recommendations and safety considerations forical implants and
devices. J Magn Reson Imaging:929.k FG. Metallic neurosurgical
implants: evaluation oftic eld interactions, heating, and artifacts
atla. J Magn Reson Imaging 2001;14:2959.k FG. Biomedical implants
and devices: assessmentnetic eld interactions with a 3.0-tesla MR
system. Jeson Imaging 2002;16:7216.DC. Recent developments and
prospects in dentalrs. J Prosthet Dent 1962;12:106678.rg AJ,
Burstone CJ, Hadjinikolaou I, Jancar J. Screeningices and bers for
reinforced thermoplasticsd for dental applications. J Biomed Mater
Res:16773.
PK, Lassila VP. Reinforcement of acrylic resine base material
with metal or bre strengtheners. Jhabil 1992;19:22530.
PK, Sevelius C. Resin-bonded, glass ber reinforcedsite xed
partial dentures a clinical study. J Prosthet00;84:4138.
boco
[14] ZhStopim20
[15] PeK.re62
[16] HotracoIn
[17] MScfocopa
[18] Kuofcoimah
[19] VaMSi
[20] KrTe
[21] Viman20
[22] TubocoM
[23] RobeTe
[24] MThprOt
[25] Pequan20
[26] Mmshcu
[27] TumphSc
[28] LaFlM
[29] ChInedglDe
[30] NoofPhconstruction with bioactive ber-reinforcedsite
implant. Head Neck 2014;36:7228.S, Moritz N, Laurila P, Mattila R,
Lassila LVJ,berg N, et al. Development of a biomechanicallyzed
multi-component ber-reinforced compositet for load-sharing
conditions. Med Eng Phys:4619.
M, Vallittu PK, Vuorinen V, Aho A, Puntala A, Aitasalol
composite implant in craniofacial bone
truction. Eur Arch Otorhinolaryngol 2012;269:
ul S, Ho KM. Decompressive craniectomy for severetic brain
injury: the relationship between surgicalcations and prediction of
an unfavourable outcome.2014;45:13329.
KD, Franz B, Kirsch M, Polanski W, vod der Hagen M,ert G, et al.
Autologous bone ap cranioplastyng decopressive craniectomy is
combined with a highcation rate in pediatric traumatic brain
injurys. Acta Neurochir (Wien) 2014;156:81324.to N, Vallittu PK,
Lassila LVJ, Huumonen S. Evaluationsity of artifacts in cone beam
CT by radiopacity of
site material and simplied simulation models ofts in vitro.
Dentomaxillofac Radiol 2014:2014157 [Epubof print].
PK. Glass bers in ber-reinforced composites. In:nna J:, editor.
Handbook of oral biomaterials.ore: Pan Stanford Publishing; 2014.
p. 2014.el H [Ph.D. thesis] Fibre reinforcement. Copenhagen:cal
University of Denmark; 1963.n EK, Skrifvars M, Vallittu PK.
Dendrimer/methylrylate copolymers: residual methyl methacrylategree
of conversion. J Biomater Sci Polym Ed:121931.M-R, Peltola MJ,
Tirri T, Lassila LVJ, Vallittu PK. Frontal
efect repair with experimental glassber-reinforcedsite with
bioactive glass granule coating. J Biomedes B: Appl Biomater
2007;82:14955.
MR. From treating solution to ller surface and. The life history
of a silane coupling agent. J Coatl 1978;50:7082.nna JP, Dahl JE,
Karlsson S, Lassila LVJ, Vallittu PK.ect of the novel silane system
to the exuralties of E-glass ber reinforced composites.
Silanesoupling Agents 2009;5:10721.ldt A, Asmussen E. The effect of
postcuring ony of remaining double bonds, mechanical
propertiesvitro wear of two resin composites. J Dent:44752.,
Ferracane J, Lee IB. Effect of shrinkage strain,s and instrument
compliance on polymerizationge stress of light-cures composites
during the initialstage. Dent Mater 2010;26:102433.M-R, Puska MA,
Lassila LVJ, Vallittu PK. Residualers released from glass
bre-reinforced compositeolymersed in contact with bone and blood. J
Materer Med 2005;16:1520.
LVJ, Tanner J, Le Bell A-M, Narva K, Vallittu PK.l properties of
ber reinforced root canal posts. Dent004;20:2936.isinoff NP.
Handbook of ceramics and composites.nstein GW, Schmiemann A,
Bledzki A, Spaude R,. Chapter 9 Corrosion phenomena
inber-reinforced thermosetting resins. USA: Marcel; 1990. p.
23168.m E, Watson H, Engstrm J, Rosenholm J. Treatmentss bers with
acid, base and silanes. Colloids Surf A:chem Eng Asp
2001;194:1438.
-
380 d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381
[31] Bouillaguet S, Schutt A, Alander P, Vallittu PK, Schwaller
P,Buerki degradber-reBiomat
[32] VallittuexuraProstho
[33] Lastumbulk bdentur
[34] Peluso Tajanareinfor1991;12
[35] Peluso Macropber-ep1991;25
[36] KostoryBurmametabo2003;82
[37] Vallittubre-pJ Oral R
[38] VkipaIn vitrowith n
[39] HautamOsteobglass c
[40] Ballo ABone tiimplan2009;20
[41] Hench [42] Karlsso
science[43] Ylnen
in SBF bioacti2000;27
[44] Marcollayer foglass 1997;37
[45] JakkolaIn vitrocompobioacti
[46] KellomWaris Tregene
[47] Varila Lbehaviimplan
[48] Hench 2009;29
[49] Hoppebiologibioacti27577
[50] Stoor PbioactiScand
[51] Stoor Prepair respira
Haemophilus inuenzae and Streptococcus pneumonia. J Biomedater
Rppr, et aport08;19unuk
Zhaninica08;19ang rola
six b10;93ccacoactitrodugangarouslciumass.
Dgerlurabil10;51gerluocomopan001m JJ,llombric mudy
i10;93htonmpoplicaechaal O,rticuler lo14;30usa
al. Rbbitsass
g08;84lingsplan06;31dulmllittuermompo14;25dulmllittusGMAater S
Vallseoinmer97;12e SY,year vel ar10;37inya. Str
compG, et al. Hydrothermal and mechanical stressese ber-matrix
interfacial bond strength in dentalinforced composites. J Biomed
Mater Res B: Appler 2006;76:98105.
PK. Effect of ten years of in vitro aging on thel properties of
ber-reinforced resin composites. Int Jdont 2007;20:435.ki T,
Lassila L, Vallittu PK. Flexural properties ofer-reinforced
composite DC-Tell used in xed partiales. Int J Prosthodont
2001;14:226.G, Ambrosio L, Cinquegrani M, Nicolais L, Saiello
S,
G. Rat peritonela immune response to carbon berced epoxy
composite implants. Biomater:2315.G, Ambrosio L, Cinquegrani M,
Nicolais L, Tajana G.hage activation induced by different carbonoxy
resin composites. J Biomed Mater Res:63749.z EL, Eick JD, Glaros
AG, Judy BM, Welshons WV,
ster S, et al. Biocompatibility of hydroxylatedlites of BISGMA
and BFDGE. J Dent Res:36771.
PK, Ekstrand K. In vitro cytotoxicity ofolymethyl methacrylate
composite used in dentures.ehabil 1999;26:66670.rta M, Koskinen MK,
Vallittu P, Nrhi T, Yli-Urpo A.
cytotoxicity of E-glass ber weave preimpregnatedovel biopolymer.
J Mater Sci Mater Med 2004;15:6974.ki M, Meretoja VV, Mattila RH,
Aho AJ, Vallittu PK.
last response to polymethyl methacrylate bioactiveomposite. J
Mater Sci Mater Med 2010;21:168592.M, Acka EA, Ozen T, Lassila L,
Vallittu PK, Nrhi TO.ssue responses to glass ber-reinforced
compositets a histometric study. Clin Oral Implants Res:60815.LL.
Bioceramics. J Am Ceram Soc 1998;81:170528.n KH. Bone implants a
challenge to materials. Ann Chir Gynaecol 1999;88:22635.
H, Itl A, Karlsson KH, Aro HT. Effect of immersionon porous
bioactive bodies made by sinteringve glass microspheres. J
Non-Cryst Solids5:10715.ongo M, Ducheyne P, LaCourse WC. Surface
reactionrmation in vitro on dense composite of a bioactivebers and
polysulfon. J Biomed Mater Res:4408.
T, Rich J, Tirri T, Nrhi T, Aho A, Seppl J, et al. Ca-P
formation on biodegradable thermoplasticsite of
poly(-caprolactone-co-dl-lactide) andve glass (S53P4). Biomaterials
2004;25:57581.ki M, Niiranen H, Puumanen K, Ashammakhi N,, Trml P.
Bioabsorbable scaffolds for guided boneration and generation.
Biomaterials 2000;21:2495505., Lehtonen T, Tuominen J, Hupa M, Hupa
L. In vitro
our of three biocompatible glasses in compositets. J Mater Sci
Mater Med 2012;23:242535.LL. Genetic design of bioactive glass. J
Eur Ceram Soc:125765.
A, Gldal NS, Boccaccini AR. A review of thecal response to ionic
dissolution products fromve glasses and glass-ceramics.
Biomaterials 2011;32:4., Sderling E, Salonen JI. Antibacterial
effects of ave glass paste on oral microorganisms. Acta
Odontol1998;56(3):1615., Sderling E, Grenman R. Bioactive glass
S53P4 inof septal perforations and its interactions with thetory
infection-associated microorganisms
M[52] Le
Mim20
[53] MT,cl20
[54] ZhEeof20
[55] Bobiin
[56] Npocagl
[57] Fadu20
[58] Fabipr54
[59] AlKefast20
[60] Lecoapm
[61] Orpal20
[62] Tuetragl20
[63] Elim20
[64] AbVathco20
[65] AbVaBiM
[66] Deosnu19
[67] Le3-le20
[68] ShPKa es 2001;58(1):11320.anta O, Vaahtio M, Peltola T,
Zhang D, Hupa L, Hupal. Antibacterial effect of bioactive glasses
on clinicallyant anaerobic bacteria in vitro. J Mater Sci Mater
Med(2):54751.ka E, Leppranta O, Korkeamki M, Vaahtio M, Peltolag D,
et al. Bactericidal effects of bioactive glasses on
lly important aerobic bacteria. J Mater Sci Mater Med(1):2732.D,
Leppranta O, Munukka E, Ylnen H, Viljanen MK,E, et al.
Antibacterial effects and dissolution behaviorioactive glasses. J
Biomed Mater Res AA(2):47583.cini AR, Jones JR, Chen QZ. Composites
containingve glass. In: Jones JR, Clare AC, editors. Bio-glasses:
anction. Chichester: Wiley; 2012. p. 12138.
S, Zhang D, Moritz N, Vallittu P, Hupa L. Multi-layer
ber-reinforced composites for implants: in vitro
phosphate formation in the presence of bioactiveent Mater
2012;28(11):113445.nd S, Ek P, Hupa M, Hupa L. On determining
chemicality of glasses. Glass Technol: Eur J Glass Sci Technol
A(6):23540.nd S, Hupa L, Hupa M. Dissolution patterns ofpatible
glasses in 2-amino-2-hydroxymethyl-e-1,3-diol (Tris) buffer. Acta
Biomater 2013;9(2):0.
Frantzn JPA, Moritz N, Lankinen P, Tukiainen M,ki M, et al. In
vivo testing of a biodegradable wovenade of bioactive glass bers
and PLGA80a pilot
n the rabbit. J Biomed Mater Res B: Appl MaterB(2):57380.en TJ,
Tuominen JU, Hiekkanen E. Resorbablesites with bioresorbable glass
bers for load-bearingtions. In vitro degradation and
degradationnism. Acta Biomater 2013;9:486877.
Lassila LV, Kumbuloglu O, Vallittu PK. Bioactive glasslate ller
composite: effect of coupling of llers andading on some physical
properties. Dent Mater:5707.
SM-R, Peltola MJ, Tirri T, Puska MA, Rytt A, Aho H,econstruction
of critical size calvarial bone defect in
with glassber-reinforced composite with bioactiveranule coating.
J Biomed Mater Res B: Appl Biomater:5109.en JE, Thomsen P,
Lyngstaads P. Advances in dentalt materials and tissue
regeneration. Periodontol 2000:13652.ajeed AA, Walboomers XF,
Massera J, Kokkari AK,
PK, Nrhi TO. Blood and broblast responses toset
BisGMATEGDMA/glass ber-reinforcedsite implants in vitro. Clin Oral
Implants Res:84351.ajeed AA, Kokkari AK, Kpyl J, Massera J, Hupa
L,
PK, et al. In vitro blood and broblast responses
toTEGDMA/bioactive glass composite implants. Jci Mater Med
2014;25:15162.e V, Faulkner G, Wolfaardt J. Craniofacialtegrated
implant-induced strain distribution: a
ical study. Int J Oral Maxillofac Implants:20010.
Piao CM, Koak JY, Kim SK, Kim YS, Ku Y, et al. Aprospective
radiographic evaluation of marginal boneound different implant
systems. J Oral Rehabil:53844.
A, Ballo AM, Lassila LV, Shinya A, Nrhi TO, Vallittuess and
strain analysis of the bone-implant interface:arison of
ber-reinforced composite and titanium
-
d e n t a l m a t e r i a l s 3 1 ( 2 0 1 5 ) 371381 381
implants utilizing 3-dimensional nite element study. J
OralImplantol 2011;37. Spec No: 133-40.
[69] Ballo AM, Kokkari A, Meretoja VV, Lassila LL, Vallittu
PK,Nrhi TO. Osteoblast proliferation and maturation onbioactive
ber-reinforced composite. J Mater Sci Mater Med2008;19:316977.
[70] Ballo AM, Lassila LV, Vallittu PK, Nrhi TO. Load
bearingcapacity of bone anchored ber-reinforced compositedevice. J
Mater Sci Mater Med 2007;18:202531.
[71] Ballo AM, Acka E, Ozen T, Moritz N, Lassila L, Vallittu P,
et al.Effect of implant design and bioactive glass coating
onbiomechanical properties of ber-reinforced compositeimplants. Eur
J Oral Sci 2014;122:3039.
[72] Ormianer Z, Lewinstein I, Moses O. Heat generation
in1-piece implants during abutment preparation withhigh-speed
cutting instruments. Implant Dent 2013;22:605.
[73] Berglundh T, Abrahamsson I, Welander M, Lang NP, Lindhe
J.Morphogenesis of the peri-implant mucosa: anexperimental study in
dogs. Clin Oral Implants Res2007;18:18.
[74] Abrahamson I, Berglundh T, Lindhe J. The mucosal
barrierfollowing abutment dis/reconnection. An experimentalstudy in
dogs. J Clin Periodontol 1997;24:56872.
[75] Iglhaut G, Becker K, Golubovic V, Schliephake H,
MichatovicI. The impact of dis-/reconnection of laser microgrooved
andmachined implant abutments on soft and hard tissuehealing. Clin
Oral Implants Res 2013;24:3917.
[76] Ramakrishna S, Mayer J, Wintermantel E, Leon KW.Biomedical
applications of polymer-composite materials: areview. Compos Sci
Technol 2001;61:1189.
[77] Asmussen E, Peutzfeldt A. Inuence of UEDMA BisGMA andTEGDMA
on selected mechanical properties of experimentalresin composites.
Dent Mater 1998;14:515.
[78] Andersson H, Liu G, Karlsson K, Niemi L, Miettinen
J,Juhanoja J. In vivo behaviour of glasses in
theSiO2Na2OCaOP2O5Al2O3B2O3 system. J Mater Sci MaterMed
1990;1(4):21927.
[79] Brink M, Turunen T, Happonen R, Yli-Urpo A.
Compositionaldependence of bioactivity of glasses in the
systemNa2OK2OMgOCaOB2O3P2O5SiO2. J Biomed Mater
Res1997;37:11421.
[80] Rochester JR. Bisphenol A and human health: review of
theliterature. Reprod Toxicol 2013;42:13255.
[81] Kang YG, Kim JY, Kin J, Won PJ, Nam JH. Release of
bisphenolA from resin composite used to bond orthodontic
lingualretainers. Am J Orthod Dentofacial Orthop
2011;140:77989.
Fiber glassbioactive glass composite for bone replacing and bone
anchoring implants1 Introduction2 Structure and material components
of FRC2.1 Resin matrix2.2 Reinforcing fibers2.3 Biological
considerations
3 Bioactive glasses4 Implant designs preclinical studies5 Future
direction of researchAcknowledgementsReferences